about
Transthoracic echocardiography in the evaluation of pediatric pulmonary hypertension and ventricular dysfunctionNon-Invasive Imaging for Congenital Heart Disease: Recent Innovations in Transthoracic Echocardiography.Systolic right ventricular function in children and young adults with pulmonary artery hypertension secondary to congenital heart disease and tetralogy of Fallot: tricuspid annular plane systolic excursion (TAPSE) and magnetic resonance imaging dataTricuspid annular peak systolic velocity (S') in children and young adults with pulmonary artery hypertension secondary to congenital heart diseases, and in those with repaired tetralogy of Fallot: echocardiography and MRI data.Near-infrared spectroscopy for objectifying cerebral effects of laser acupuncture in term and preterm neonates.Changes of locoregional skin temperature in neonates undergoing laser needle acupuncture at the acupuncture point large intestine 4Laser Acupuncture for Neonatal Abstinence Syndrome: A Randomized Controlled Trial.Effects of Exercise and Nutrition on the Coagulation System During Bedrest Immobilization.Orthostatic Challenge Shifts the Hemostatic System of Patients Recovered from Stroke toward Hypercoagulability.Incidence and natural history of neonatal isolated ventricular septal defects: Do we know everything? A 6-year single-center Italian experience follow-up.Executive summary. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.Pediatric echocardiographic nomograms: What has been done and what still needs to be done.Diagnostics in Children and Adolescents with Suspected or Confirmed Pulmonary Hypertension.Left ventricular long-axis function: reference values of the mitral annular plane systolic excursion in 558 healthy children and calculation of z-score values.Right ventricular function in infants, children and adolescents: reference values of the tricuspid annular plane systolic excursion (TAPSE) in 640 healthy patients and calculation of z score values.Effects of melagatran on activated partial thromboplastin time and on ecarin clotting time in cord versus adult plasma.Drotrecogin alfa (activated, Xigris) in combination with heparin or melagatran: an in vitro investigation.Cardiac magnetic resonance imaging and echocardiography in pediatric pulmonary arterial hypertension.Right Ventricular Outflow Tract Velocity Time Integral Determination in 570 Healthy Children and in 52 Pediatric Atrial Septal Defect Patients.Anticoagulant action of low, physiologic, and high albumin levels in whole blood.High availability of intravascular tissue factor in neonates.Effects of nadroparin, enoxaparin, and unfractionated heparin on endogenous factor Xa and IIa formation and on thrombelastometry profiles.Remote monitoring leads to early recognition and treatment of critical arrhythmias in adults after atrial switch operation for transposition of the great arteries.Right ventricular performance in preterm and term neonates: reference values of the tricuspid annular peak systolic velocity measured by tissue Doppler imaging.Reference values of the right ventricular outflow tract systolic excursion in 711 healthy children and calculation of z-score values.Thrombin generation in paediatric patients with congenital heart disease. Determination by calibrated automated thrombography.Right ventricular long-axis response to different loading conditions.Longitudinal systolic ventricular interaction in pediatric and young adult patients with TOF: a cardiac magnetic resonance and M-mode echocardiographic study.The respective and combined anticoagulant effects of recombinant human activated protein C, melagatran and heparins using CAT.Subclinical deterioration of systolic right ventricular function parameters in adolescents with mild cystic fibrosis.Signs of thrombin generation in pediatric cardiac catheterization with unfractionated heparin bolus or subcutaneous low molecular weight heparin for antithrombotic cover.Pediatric patients with congenital heart disease: thrombin generation measured by calibrated automated thrombography.Combined effects of melagatran and eptifibatide on platelet aggregation inhibition but not thrombin generation inhibition.M-Mode and tissue Doppler imaging derived normal values of left and right ventricular function in healthy infants.Anticoagulant action of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, in umbilical cord and adult plasma: an in vitro examination.Drotrecogin alfa activated (recombinant human activated protein C) in combination with heparin or melagatran: effects on prothrombin time and activated partial thromboplastin time.Importance of quantifiable right heart systolic function evaluation using tricuspid annular plane systolic excursion (TAPSE) in fetuses and neonates.Reference values of tricuspid annular peak systolic velocity in healthy pediatric patients, calculation of z score, and comparison to tricuspid annular plane systolic excursion.Transthoracic echocardiography for the evaluation of children and adolescents with suspected or confirmed pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European PaediatricA left-to-right shunt via the ductus arteriosus is associated with increased regional cerebral oxygen saturation during neonatal transition.
P50
Q26750989-99702B88-A3F1-4791-9A4A-2B3C0C481BDBQ30448090-7142F12B-94EE-4B1F-A69B-7CD302BB6EDCQ34228910-8671520F-C07E-4986-A0C0-0789F8422D1CQ34326969-92C0F391-17C7-4CF8-AEEB-294976E6ACD4Q34769308-2D6658F0-05F4-4509-B4DF-15151BEE84CCQ35438199-CA2AF4BB-71BC-4470-86F5-AA7BE6743E53Q35822330-CE2A550F-D36B-44DC-9AE5-53148BEFA69EQ36255931-30443BD7-7918-4384-A64E-F9DE5BC7DC55Q37627161-9C3DE3D6-7811-4EA4-B597-D692821B46B6Q38600490-922C807A-7A1E-412B-A8D3-F788513D1EBBQ38800327-F74F3E20-BF84-4540-A440-C1D51BAA32B1Q38954223-9D307A87-D60B-486C-83E5-6446159EA9A0Q39037831-AF0FAF00-0045-4204-B786-B1829158C91CQ39586323-3B436D1D-D72F-44FC-9435-14DC1F5BB308Q39981595-B7B2EB73-AB82-44A7-9B5B-FD15E372F731Q40270194-A716B9DC-CFC5-4F01-99F1-2E6C3422DCA8Q40441242-13C101CA-9447-4E9E-B529-F7A093C2B394Q41176842-3F3EA20C-271E-40DA-9879-BF35CED4C61EQ41285437-48046CBA-66DE-4732-A481-DD56BFACE39EQ41363216-A94EC02A-E6EB-49EB-AC92-5B09B3298EBAQ42512252-439921C6-9E05-470A-A870-1777364DCF50Q43118157-5A036B93-ADB1-46E3-B8AD-1604839E1621Q43515789-979212F6-8D63-4CFC-804C-612316A69A46Q43600265-7FA1A456-DA46-4911-8283-D496DFA7420DQ43662655-83A88DA7-52C0-40DF-844C-B448C60651ABQ44447504-B06685AC-2959-4C9C-BA9C-E18FA91192B2Q44472233-BF7A1402-4571-4BB6-A8C0-E5357470ECC4Q44518123-A803A15A-C548-490C-AE1B-8F5ECB120FF0Q44521971-F8AA6E57-46FB-4190-856F-C1613A9032E1Q44535371-A3D1EAEA-2C02-4E4B-B025-D75CAE9A63CDQ44708633-8E5FE1B2-F09F-4D1B-A040-A8A47580AF6AQ44807237-2E80C5E7-06BD-4404-9365-2D32D2319BADQ44848549-243916AA-43D1-495C-A097-8678F1AA56C6Q45050274-F9B86448-B61C-44A0-AD3F-67EE4C800233Q45165025-84C85A19-2E1B-4017-A4A7-745AA609CCDFQ45197778-2F2CD1D3-A57F-4D9E-AD22-15CE4BB9D82BQ45266111-93770A34-F2DD-4A0B-A9FB-233D251891E6Q45360939-6E26C6FE-E034-4510-BBBE-24775EEBE990Q45714265-EBE5B934-9D97-4CFC-83FC-C954BAA6C9DEQ45771714-A3AE527C-BAAB-4DCD-A78E-5C7674B7F469
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Martin Koestenberger
@ast
Martin Koestenberger
@en
Martin Koestenberger
@es
Martin Koestenberger
@nl
Martin Koestenberger
@sl
type
label
Martin Koestenberger
@ast
Martin Koestenberger
@en
Martin Koestenberger
@es
Martin Koestenberger
@nl
Martin Koestenberger
@sl
altLabel
Martin
@en
prefLabel
Martin Koestenberger
@ast
Martin Koestenberger
@en
Martin Koestenberger
@es
Martin Koestenberger
@nl
Martin Koestenberger
@sl
P106
P21
P31
P496
0000-0003-1766-7859